Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
26.39
+1.86 (7.58%)
Jan 22, 2025, 4:00 PM EST - Market closed
Beam Therapeutics Market Cap
Beam Therapeutics has a market cap or net worth of $2.10 billion as of January 22, 2025. Its market cap has increased by 1.76% in one year.
Market Cap
2.10B
Enterprise Value
1.23B
1-Year Change
1.76%
Ranking
Category
Stock Price
$26.39
Market Cap Chart
Since February 6, 2020, Beam Therapeutics's market cap has increased from $327.97M to $2.10B, an increase of 540.43%. That is a compound annual growth rate of 45.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2025 | 1.95B | -1.09% |
| Dec 31, 2024 | 1.97B | -8.58% |
| Dec 29, 2023 | 2.16B | -19.78% |
| Dec 30, 2022 | 2.69B | -49.47% |
| Dec 31, 2021 | 5.33B | 15.54% |
| Dec 31, 2020 | 4.61B | 1,305.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 680.73B |
| UnitedHealth Group | 479.30B |
| Novo Nordisk | 355.54B |
| Johnson & Johnson | 344.58B |
| AbbVie | 299.49B |
| Merck & Co. | 242.01B |
| Thermo Fisher Scientific | 220.40B |
| Intuitive Surgical | 217.38B |